TERN

Q: What is the price of Terns Pharmaceuticals (TERN) today?

The current price of Terns Pharmaceuticals (TERN) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 40.40 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Terns Pharmaceuticals (TERN) pay dividends?

Terns Pharmaceuticals (TERN) did not pay dividends over the past year.

Terns Pharmaceuticals Inc.

Price

$ -

return (12m)

0.00%

p/e

-53.94

p/bv

5.16

DIVIDEND YIELD

0.00%

TERN price

TERN

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TERN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals TERN

review the fundamentals of Terns Pharmaceuticals shares

P/E

-53.94

Sector: -2.96 Industry: 0.83

P/S (PSR)

Sector: 1.86 Industry: 2.35

P/BV

5.16

Sector: 2.05 Industry: 2.29

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-9.39%

Sector: -29.54% Industry: -26.96%

ROE

-9.56%

Sector: -38.83% Industry: -37.23%

ROIC

-1,404.48%

Sector: -443.10% Industry: -95.45%

NET MARGIN

0.00%

Sector: -31.47% Industry: -32.02%

GROSS MARGIN

0.00%

Sector: 43.63% Industry: 49.98%

OPERATING MARGIN

0.00%

Sector: -26.60% Industry: -28.54%

EV/EBITDA

-47.33

Sector: -0.92 Industry: 0.70

EV/EBIT

-47.12

Sector: -2.65 Industry: -0.15

PRICE-TO-ASSETS

5.06

Sector: 1.11 Industry: 1.28

BVPS

10.27

Sector: 3.83 Industry: 5.06

EPS

-0.98

Sector: -1.01 Industry: -0.74

EQUITY-TO-ASSETS RATIO

0.98

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.02

Sector: 0.45 Industry: 0.50

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

13.91%

Sector: - Industry: -

Fundamentals TERN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	37.67	30.52	81.02%	0.59%	$ 952.11 B	34.99%
ISRG	52.21	8.84	16.93%	0.00%	$ 155.53 B	28.15%
SNY	7.24	1.29	17.79%	4.99%	$ 108.11 B	14.75%
TMO	24.35	3.20	13.15%	0.39%	$ 166.76 B	15.15%
NVS	21.44	7.45	34.77%	2.04%	$ 290.19 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.86	2.05	9.38%	3.61%	$ 100.84 B	13.00%
GSK	13.07	4.41	33.77%	3.44%	$ 102.50 B	17.79%
CVS	40.49	1.53	3.78%	2.85%	$ 118.72 B	0.72%
BSX	24.23	3.34	13.78%	0.00%	$ 86.38 B	17.29%
TMDX	13.63	4.74	34.80%	0.00%	$ 2.34 B	27.04%
HCA	12.99	-29.64	-228.14%	0.75%	$ 88.27 B	8.89%
IDXX	40.86	28.76	70.38%	0.00%	$ 44.75 B	24.63%
RMD	19.85	4.65	23.41%	1.12%	$ 30.17 B	27.44%
DHR	33.01	2.30	6.97%	0.79%	$ 121.78 B	14.89%
INMD	9.93	1.31	13.18%	0.00%	$ 865.62 M	23.27%
PHG	21.85	1.87	8.56%	3.42%	$ 24.68 B	5.50%
SYK	36.22	5.26	14.52%	1.09%	$ 120.87 B	13.21%
FMS	10.81	0.72	6.71%	3.64%	$ 11.90 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

TERN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Terns Pharmaceuticals

Terns Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

10 years

Founded: 2016

2021

Time since IPO - 5 years

30

Employees

Terns Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1,000.00 Trillions, with shareholders equity totaling $1.01 Billion.

The company employs approximately 30 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Terns Pharmaceuticals Inc. reported $- in revenue, generating net income of $-96.21 Millions.

Key financial metrics include a P/E ratio of -53.94, a price-to-book (P/B) ratio of 5.16, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TERN.

Market cap

$ 1,000.00 Trillions

Net worth

$ 1.01 Billion

$ 1,006,520,000.00

Assets

$ 1.03 Billion

$ 1,025,080,000.00

Total Shares Outstanding

98.00 Millions

98,000,000

Average Daily Trading Volume

$ 6.61 Millions

$ 6,609,231.52

Sector

Health

Industry

Pharmaceutical Products

TERN

TERN revenue and profits

Financial Results TERN

DRAG THE FRAME TO SEE MORE DATA

TERN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 93.26 58,90% (12M)

P/E

40.49

2.85%

ROE

3.78%

P/BV

1.53

CI - Cigna

$ 286.24 --7,51% (12M)

P/E

11.64

2.13%

ROE

15.39%

P/BV

1.79

CNC - Centene

$ 59.14 4,84% (12M)

P/E

-4.52

0.00%

ROE

-29.93%

P/BV

1.35

HUM - Humana

$ 307.95 39,06% (12M)

P/E

32.70

1.15%

ROE

6.06%

P/BV

1.98

SNY - Sanofi

$ 44.29 --11,03% (12M)

P/E

7.24

4.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,065.00 47,95% (12M)

P/E

37.67

0.59%

ROE

81.02%

P/BV

30.52

HCA - HCA Healthcare

$ 394.07 5,54% (12M)

P/E

12.99

0.75%

ROE

-228.14%

P/BV

-29.64

NVS - Novartis

$ 152.01 37,44% (12M)

P/E

21.44

2.04%

ROE

34.77%

P/BV

7.45